Nano-radiosensitizers targeting tumor radioresistance: mechanisms, rational design, and clinical prospects
Chemical Communications · 2026 · 62 (56) · 13955-13980
DOI: 10.1039/d6cc03471c ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Chemical Communications, 2026. Verfasst von Kaiye Wang und 4 weiteren Autor:innen. Beteiligte Einrichtung: College of Chemistry, Chemical Engineering and Materials Science, Key Laboratory of Molecular and Nano Probes, Ministry of Education, Collaborative I…. Hauptthemen laut MEDLINE: Radiation-Sensitizing Agents, Neoplasms, Radiation Tolerance. Die Arbeit nennt 153 Literaturangaben. Gefördert von: Postdoctoral Innovation Project of Shandong Province, Postdoctoral Research Foundation of China, Natural Science Foundation of Shandong Province.
Abstract (Originalsprache)
Recent advances in rational design of nano-radiosensitizers targeting tumor radioresistance mechanisms.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- College of Chemistry, Chemical Engineering and Materials Science, Key Laboratory of Molecular and Nano Probes, Ministry of Education, Collaborative Innovation Center of Functionalized Probes for Chemical Imaging in Univ…
Förderung
- Postdoctoral Innovation Project of Shandong Province
- Postdoctoral Research Foundation of China
- Natural Science Foundation of Shandong Province
Zitieren
APA
Wang, K., Liu, X., Jia, Y., Pan, W., & Li, N. (2026). Nano-radiosensitizers targeting tumor radioresistance: mechanisms, rational design, and clinical prospects. Chemical Communications, 62(56), 13955-13980. https://doi.org/10.1039/d6cc03471c
Vancouver
Wang K, Liu X, Jia Y, Pan W, Li N. Nano-radiosensitizers targeting tumor radioresistance: mechanisms, rational design, and clinical prospects. Chemical Communications. 2026;62(56):13955-13980. doi:10.1039/d6cc03471c
BibTeX
@article{Wang2026,
author = {Wang, Kaiye and Liu, Xiaohan and Jia, Yuting and Pan, Wei and Li, Na},
title = {Nano-radiosensitizers targeting tumor radioresistance: mechanisms, rational design, and clinical prospects},
journal = {Chemical Communications},
year = {2026},
volume = {62},
number = {56},
pages = {13955--13980},
doi = {10.1039/d6cc03471c}
}
EUVIMED